Inhibited NF-κB activation and pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) in TNBS-induced colitis; increased IL-10, inhibited Th17 cell differentiation, and promoted Treg cell differentiation in the colonic lamina propria. Here, NFKB1 is linked to colitis.